Cited by 81Inflammatory Bowel DiseaseOcular Diseases and Behçet’s SyndromeMicroscopic Colitis

Emerging trends of inflammatory bowel disease in South Korea: A nationwide population‐based study

Kwak, Min Seob, Cha, Jae Myung, Lee, Hun Hee, Choi, Yong Sung, Seo, Seung In, Ko, Kyung Jin, Park, Dong Il, Kim, Sung Hun +1 more·2019·Journal of Gastroenterology and Hepatology

Abstract

Background and Aim: Little is known regarding the exact burden of inflammatory bowel disease (IBD) in Asian countries because previous epidemiologic studies were hospital based. We aimed to develop and validate an operational definition of IBD cases from health insurance claims data and to examine the epidemiological features of IBD in Korea. Methods: We analyzed stratified sample data from the Korean Health Insurance Review and Assessment (2010–2016) database using 12 different definitions and applied the best definition to the entire (2007–2016) dataset. Results: The definition that combined the International Classification of Disease 10th revision code with IBD‐specific medications had the best performance characteristics among the 12 tested definitions. During the 8‐year study period, IBD prevalence increased from 25 345 in 2009 to 47 444 in 2016. Over that period, the prevalence of Crohn's disease increased 1.9‐fold (from 16.0/100 000 in 2009 to 29.6/100 000 in 2016) and that of ulcerative colitis increased 1.6‐fold (from 41.4/100 000 in 2009 to 66.0/100 000 in 2016). Similarly, the estimated incidence of Crohn's disease also increased 1.2‐fold (from 2.4 to 2.9 per 100 000) and that of ulcerative colitis rose 1.3‐fold (from 4.0 to 5.3 per 100 000). During the study period, the predominant increase in IBD incidence was among younger individuals, especially those aged < 30 years. Conclusion: Patients with IBD can be accurately identified using Korean insurance claims data by combining information regarding the International Classification of Disease 10th revision codes and the IBD medications used. The prevalence of IBD continues to increase, with an apparent shift toward younger (< 30 years) age groups.

Integrity signals

Registry

Crossref · 10.1111/jgh.14542

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In South Korea, IBD prevalence was 57.37 per 100,000 in 2009 and had not quite doubled to 95.59 per 100,000 in 2016, suggesting a Prevalence Doubling Period near 10 years.

    “By contrast, in South Korea, which began westernizing earlier, the prevalence of IBD was 57.37 per 100,000 in 2009, but had not quite doubled to 95.59 per 100,000 in 2016, suggesting a Prevalence Doubling Period closer to 10 years79.”
  • South Korean IBD prevalence was 42 per 100,000 in 2005, 63.8 per 100,000 in 2010, and 92.8 per 100,000 in 2015.

    “Similarly, the prevalence of IBD in South Korea was 42 per 100,000 in 2005 (ref.88), 63.8 per 100,000 in 2010 and 92.8 per 100,000 in 2015 (ref.79).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kwak, M. S., Cha, J. M., Lee, H. H., Choi, Y. S., Seo, S. I., Ko, K. J., Park, D. I., Kim, S. H., & Kim, T. J.
Affiliations
  • Kyung Hee University (KR)
  • Daehang Hospital (KR)
  • Hallym University (KR)
  • Kangbuk Samsung Hospital (KR)
  • Veterans Health Service Medical Center (KR)
  • Samsung Medical Center (KR)
Corresponding author
Cha, Jae Myung
Venue
Journal of Gastroenterology and Hepatology
Publisher
Wiley
Published
2018-12-10
Volume
34
Issue
6
Pages
1018-1026
ISSN
  • 0815-9319 (ISSN-L)
  • 1440-1746
OpenAlex
W2901753975
Cited by
81
References
29
Citations by year
2026: 4 · 2025: 5 · 2024: 11 · 2023: 13 · 2022: 18 · 2021: 19 · 2020: 8 · 2019: 3
FWCI
4.60
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Gastroenterology and Hepatology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Research Foundation of Korea
  • Ministry of Science, ICT and Future Planning (NRF‐2017R1E1A1A01076359)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Epidemiology › Microscopic Colitis
Keywords
inflammatory bowel disease, Crohn's disease, ulcerative colitis, IBD prevalence, IBD incidence, health insurance claims data, ICD-10 codes, age distribution of disease, South Korea
MeSH terms
Adult, Age Factors, Colitis, Ulcerative, Crohn Disease, Female, Humans, Insurance Claim Review, Male, Middle Aged, Sex Factors, Time Factors, Inflammatory Bowel Diseases, Incidence, Prevalence, Cost of Illness, International Classification of Diseases, Republic of Korea

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review